Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
StockSEC filings

Kalaris Therapeutics, Inc. (KLRS): Insider Trades and Fund Holdings

What insiders and tracked funds have reported about Kalaris Therapeutics, Inc. in SEC filings.

0Insider buys, 12 months
$0Bought by insiders, 12 months
$0Sold by insiders, 12 months
1Tracked funds holding
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

Tracked funds that report KLRS

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Renaissance TechnologiesQ2 2026149,351$608K0.00%▲ +125.8%
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →